{"transactions":[{"id":1356,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:05:05.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":10257,"price":2.7408,"value":28112.3856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.7408, and the range of prices were between $2.70 and $2.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided"}],"balance_after":318480,"source":{"system":"sec-edgar","filing":"0001493152-26-041285","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226041285/ownership.xml","form_type":"4"}},{"id":1357,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-09-02T23:05:04.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":34463,"price":2.6666,"value":91899.0358,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.6666, and the range of prices were between $2.59 and $2.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided"}],"balance_after":1226427,"source":{"system":"sec-edgar","filing":"0001493152-26-041284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937573/000149315226041284/ownership.xml","form_type":"4"}},{"id":1358,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-02T23:05:02.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":9683,"price":2.7531,"value":26658.2673,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.7531, and the range of prices were between $2.70 and $2.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided"}],"balance_after":258688,"source":{"system":"sec-edgar","filing":"0001493152-26-041283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937482/000149315226041283/ownership.xml","form_type":"4"}},{"id":697019,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-08-05T00:20:11.000Z","date":"2026-08-04","kind":"sale","planned":false,"acquired":false,"shares":653,"price":2.9434,"value":1922.0402,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9434, and the range of prices were between $2.93 and $2.975. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":268371,"source":{"system":"sec-edgar","filing":"0001493152-26-036077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226036077/ownership.xml","form_type":"4"}},{"id":697467,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-08-05T00:20:10.000Z","date":"2026-08-04","kind":"sale","planned":false,"acquired":false,"shares":653,"price":2.9467,"value":1924.1951,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9467, and the range of prices were between $2.91 and $2.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":328737,"source":{"system":"sec-edgar","filing":"0001493152-26-036076","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226036076/ownership.xml","form_type":"4"}},{"id":697017,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-05T00:20:08.000Z","date":"2026-08-04","kind":"sale","planned":false,"acquired":false,"shares":3023,"price":2.9459,"value":8905.4557,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9459, and the range of prices were between $2.905 and $2.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":1260890,"source":{"system":"sec-edgar","filing":"0001493152-26-036075","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226036075/ownership.xml","form_type":"4"}},{"id":717575,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:35:21.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":12000,"price":2.9082,"value":34898.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9082, and the range of prices were between $2.87 and $2.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":91403,"source":{"system":"sec-edgar","filing":"0001493152-26-031927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226031927/ownership.xml","form_type":"4"}},{"id":732439,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36894,"kind":"person","name":"Pulisic Matthew","position":1,"cik":"0002054836","reported_name":"Pulisic Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-18T23:05:23.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":278906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter"}],"balance_after":278906,"source":{"system":"sec-edgar","filing":"0001493152-26-029421","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054836/000149315226029421/ownership.xml","form_type":"4"}},{"id":731840,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-06-18T23:05:21.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":233957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter"}],"balance_after":233957,"source":{"system":"sec-edgar","filing":"0001493152-26-029420","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029420/ownership.xml","form_type":"4"}},{"id":732351,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-06-18T23:05:20.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":174841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."}],"balance_after":329390,"source":{"system":"sec-edgar","filing":"0001493152-26-029419","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226029419/ownership.xml","form_type":"4"}},{"id":731839,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T23:05:18.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":31566,"derivative":{"exercise_price":3.03,"expiration_date":"2036-06-15","underlying":"Common stock","underlying_shares":31566},"source":{"system":"sec-edgar","filing":"0001493152-26-029418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029418/ownership.xml","form_type":"4"}},{"id":731838,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T23:05:18.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":28409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":96483,"source":{"system":"sec-edgar","filing":"0001493152-26-029418","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029418/ownership.xml","form_type":"4"}},{"id":731835,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-18T23:05:17.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":730601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1261 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":1263913,"source":{"system":"sec-edgar","filing":"0001493152-26-029417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029417/ownership.xml","form_type":"4"}},{"id":731837,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T23:05:16.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":31566,"derivative":{"exercise_price":3.03,"expiration_date":"2036-06-15","underlying":"Common stock","underlying_shares":31566},"source":{"system":"sec-edgar","filing":"0001493152-26-029416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029416/ownership.xml","form_type":"4"}},{"id":731836,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T23:05:16.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":28409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":501193,"source":{"system":"sec-edgar","filing":"0001493152-26-029416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029416/ownership.xml","form_type":"4"}},{"id":731834,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36756,"kind":"person","name":"Mirabelli Mary","position":1,"cik":"0001937525","reported_name":"Mirabelli Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T23:05:14.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":31566,"derivative":{"exercise_price":3.03,"expiration_date":"2036-06-15","underlying":"Common stock","underlying_shares":31566},"source":{"system":"sec-edgar","filing":"0001493152-26-029415","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029415/ownership.xml","form_type":"4"}},{"id":731833,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36756,"kind":"person","name":"Mirabelli Mary","position":1,"cik":"0001937525","reported_name":"Mirabelli Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T23:05:14.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":28409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":102693,"source":{"system":"sec-edgar","filing":"0001493152-26-029415","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029415/ownership.xml","form_type":"4"}},{"id":731832,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-18T23:05:12.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":119318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."}],"balance_after":269024,"source":{"system":"sec-edgar","filing":"0001493152-26-029414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029414/ownership.xml","form_type":"4"}},{"id":731831,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T23:05:11.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":31566,"derivative":{"exercise_price":3.03,"expiration_date":"2036-06-15","underlying":"Common stock","underlying_shares":31566},"source":{"system":"sec-edgar","filing":"0001493152-26-029413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029413/ownership.xml","form_type":"4"}},{"id":731830,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T23:05:11.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":28409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":103403,"source":{"system":"sec-edgar","filing":"0001493152-26-029413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226029413/ownership.xml","form_type":"4"}},{"id":749390,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2026-06-05T00:35:02.000Z","date":"2026-06-03","kind":"sale","planned":false,"acquired":false,"shares":192,"price":2.93,"value":562.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":67611,"source":{"system":"sec-edgar","filing":"0001493152-26-027348","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226027348/ownership.xml","form_type":"4"}},{"id":754339,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T00:35:01.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":2.9801,"value":29801.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9801, and the range of prices were between $2.94 and $3.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":472784,"source":{"system":"sec-edgar","filing":"0001493152-26-026930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226026930/ownership.xml","form_type":"4"}},{"id":782181,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-13T00:30:06.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":605,"price":2.9726,"value":1798.423,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9726, and the range of prices were between $2.95 and $3.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":149706,"source":{"system":"sec-edgar","filing":"0001493152-26-022567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226022567/ownership.xml","form_type":"4"}},{"id":782832,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-05-13T00:30:05.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":605,"price":2.9742,"value":1799.391,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9742, and the range of prices were between $2.96 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":154549,"source":{"system":"sec-edgar","filing":"0001493152-26-022568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226022568/ownership.xml","form_type":"4"}},{"id":782180,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-13T00:30:03.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":2798,"price":2.9398,"value":8225.5604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9398, and the range of prices were between $2.89 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":532051,"source":{"system":"sec-edgar","filing":"0001493152-26-022566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226022566/ownership.xml","form_type":"4"}},{"id":782179,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2026-05-13T00:30:02.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":270,"price":2.9796,"value":804.492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.9796, and the range of prices were between $2.97 and $2.98. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":67803,"source":{"system":"sec-edgar","filing":"0001493152-26-022565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226022565/ownership.xml","form_type":"4"}},{"id":827246,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2026-03-26T21:00:24.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":240,"price":2.51,"value":602.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":68073,"source":{"system":"sec-edgar","filing":"0001493152-26-012972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226012972/ownership.xml","form_type":"4"}},{"id":827245,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2026-03-26T21:00:24.000Z","date":"2026-03-24","kind":"sale","planned":false,"acquired":false,"shares":345,"price":2.42,"value":834.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":68313,"source":{"system":"sec-edgar","filing":"0001493152-26-012972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226012972/ownership.xml","form_type":"4"}},{"id":827464,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-26T21:00:22.000Z","date":"2026-03-24","kind":"sale","planned":false,"acquired":false,"shares":906,"price":2.42,"value":2192.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":155154,"source":{"system":"sec-edgar","filing":"0001493152-26-012971","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315226012971/ownership.xml","form_type":"4"}},{"id":827243,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Common Stock","published_at":"2026-03-26T21:00:21.000Z","date":"2026-03-24","kind":"sale","planned":false,"acquired":false,"shares":906,"price":2.42,"value":2192.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":144938,"source":{"system":"sec-edgar","filing":"0001493152-26-012970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226012970/ownership.xml","form_type":"4"}},{"id":827244,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-26T21:00:20.000Z","date":"2026-03-24","kind":"sale","planned":false,"acquired":false,"shares":3582,"price":2.42,"value":8668.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":534849,"source":{"system":"sec-edgar","filing":"0001493152-26-012969","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226012969/ownership.xml","form_type":"4"}},{"id":865980,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-04T01:05:01.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":2.8957,"value":28957.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $2.8957, and the range of prices were between $2.82 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":482784,"source":{"system":"sec-edgar","filing":"0001493152-26-008743","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226008743/ownership.xml","form_type":"4"}},{"id":944224,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":69833,"kind":"person","name":"Litten Jason","position":1,"cik":"0001909400","reported_name":"Litten Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-07T22:32:02.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":275000,"derivative":{"exercise_price":4.55,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001493152-26-000854","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226000854/ownership.xml","form_type":"4"}},{"id":972498,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Common Stock","published_at":"2025-12-12T01:50:02.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":973,"price":5.3694,"value":5224.4262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":145844,"source":{"system":"sec-edgar","filing":"0001493152-25-027338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225027338/ownership.xml","form_type":"4"}},{"id":972497,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Common Stock","published_at":"2025-12-12T01:50:02.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":3219,"price":3.3574,"value":10807.4706,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":146817,"source":{"system":"sec-edgar","filing":"0001493152-25-027338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225027338/ownership.xml","form_type":"4"}},{"id":972493,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-12T01:50:01.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":4509,"price":5.3694,"value":24210.6246,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025, and 1,452 shares acquired under the Issuer's Employee Stock Purchase Plan on November 14, 2025."}],"balance_after":538431,"source":{"system":"sec-edgar","filing":"0001493152-25-027339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225027339/ownership.xml","form_type":"4"}},{"id":972492,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-12T01:50:01.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":12673,"price":3.3267,"value":42159.2691,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025, and 1,452 shares acquired under the Issuer's Employee Stock Purchase Plan on November 14, 2025."}],"balance_after":542940,"source":{"system":"sec-edgar","filing":"0001493152-25-027339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225027339/ownership.xml","form_type":"4"}},{"id":972797,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:49:59.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":973,"price":5.3694,"value":5224.4262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":156060,"source":{"system":"sec-edgar","filing":"0001493152-25-027337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315225027337/ownership.xml","form_type":"4"}},{"id":972796,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:49:59.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":1463,"price":3.3574,"value":4911.8762,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":157033,"source":{"system":"sec-edgar","filing":"0001493152-25-027337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315225027337/ownership.xml","form_type":"4"}},{"id":972795,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-12-12T01:49:59.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":1270,"price":3.3267,"value":4224.909,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025."}],"balance_after":158496,"source":{"system":"sec-edgar","filing":"0001493152-25-027337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000149315225027337/ownership.xml","form_type":"4"}},{"id":975780,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-12-10T01:00:03.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":165,"price":4.69,"value":773.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Forms 4 filed on August 29, 2025 and September 3, 2025."}],"balance_after":68658,"source":{"system":"sec-edgar","filing":"0001493152-25-026981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225026981/ownership.xml","form_type":"4"}},{"id":975779,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-12-10T01:00:03.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":343,"price":5.3694,"value":1841.7042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Forms 4 filed on August 29, 2025 and September 3, 2025."}],"balance_after":68823,"source":{"system":"sec-edgar","filing":"0001493152-25-026981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225026981/ownership.xml","form_type":"4"}},{"id":975778,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-12-10T01:00:03.000Z","date":"2025-09-03","kind":"sale","planned":false,"acquired":false,"shares":580,"price":3.359,"value":1948.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Forms 4 filed on August 29, 2025 and September 3, 2025."}],"balance_after":69166,"source":{"system":"sec-edgar","filing":"0001493152-25-026981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225026981/ownership.xml","form_type":"4"}},{"id":975777,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-12-10T01:00:03.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":1244,"price":3.3574,"value":4176.6056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shown in Column 5 takes into account the transactions reported on Forms 4 filed on August 29, 2025 and September 3, 2025."}],"balance_after":69746,"source":{"system":"sec-edgar","filing":"0001493152-25-026981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225026981/ownership.xml","form_type":"4"}},{"id":983353,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T00:00:26.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":5.0008,"value":50008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $5.0008, and the range of prices were between $4.73 and $5.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":492784,"source":{"system":"sec-edgar","filing":"0001493152-25-025811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225025811/ownership.xml","form_type":"4"}},{"id":1049382,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":3.33,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049381,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049380,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":23568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":23568,"derivative":{"exercise_price":3.33,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":23568},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049379,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":23568},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049378,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":157372,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":157372,"derivative":{"exercise_price":3.33,"expiration_date":"2030-03-22","underlying":"Common stock","underlying_shares":157372},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049377,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":157372,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2030-03-22","underlying":"Common stock","underlying_shares":157372},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049376,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":925000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":925000,"derivative":{"exercise_price":3.33,"expiration_date":"2027-09-18","underlying":"Common stock","underlying_shares":925000},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049375,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:34.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":925000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2027-09-18","underlying":"Common stock","underlying_shares":925000},"source":{"system":"sec-edgar","filing":"0001641172-25-026398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026398/ownership.xml","form_type":"4"}},{"id":1049369,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:33.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":65000,"derivative":{"exercise_price":3.33,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001641172-25-026397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026397/ownership.xml","form_type":"4"}},{"id":1049368,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:33.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001641172-25-026397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026397/ownership.xml","form_type":"4"}},{"id":1049367,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:33.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":207652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":207652,"derivative":{"exercise_price":3.33,"expiration_date":"2029-09-20","underlying":"Common stock","underlying_shares":207652},"source":{"system":"sec-edgar","filing":"0001641172-25-026397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026397/ownership.xml","form_type":"4"}},{"id":1049366,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:33.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":207652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2029-09-20","underlying":"Common stock","underlying_shares":207652},"source":{"system":"sec-edgar","filing":"0001641172-25-026397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026397/ownership.xml","form_type":"4"}},{"id":1049373,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:31.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":8333,"derivative":{"exercise_price":3.33,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001641172-25-026396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026396/ownership.xml","form_type":"4"}},{"id":1049372,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:31.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001641172-25-026396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026396/ownership.xml","form_type":"4"}},{"id":1049371,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-09-03T20:15:31.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common Stock upon vesting. The RSUs will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 12 equal quarterly (every 3 months) installments thereafter."}],"balance_after":70990,"source":{"system":"sec-edgar","filing":"0001641172-25-026396","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026396/ownership.xml","form_type":"4"}},{"id":1050013,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":65000,"derivative":{"exercise_price":3.33,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050012,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":22.4,"expiration_date":"2033-09-10","underlying":"Common stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050011,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":13333,"derivative":{"exercise_price":3.33,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050010,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2030-09-23","underlying":"Common stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050009,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":80000,"derivative":{"exercise_price":3.33,"expiration_date":"2027-09-12","underlying":"Common stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050008,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2027-09-12","underlying":"Common stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050007,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":16666,"derivative":{"exercise_price":3.33,"expiration_date":"2026-12-30","underlying":"Common stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1050006,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T20:15:30.000Z","date":"2025-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to these options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2026-12-30","underlying":"Common stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001641172-25-026395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225026395/ownership.xml","form_type":"4"}},{"id":1052722,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:58.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":28576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":28576,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":28576},"source":{"system":"sec-edgar","filing":"0001641172-25-026003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026003/ownership.xml","form_type":"4"}},{"id":1052721,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:58.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":22283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":502784,"source":{"system":"sec-edgar","filing":"0001641172-25-026003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026003/ownership.xml","form_type":"4"}},{"id":1052720,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:57.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":478800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":478800,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":478800},"source":{"system":"sec-edgar","filing":"0001641172-25-026002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026002/ownership.xml","form_type":"4"}},{"id":1052719,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-29T20:30:57.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":361200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1514 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":554161,"source":{"system":"sec-edgar","filing":"0001641172-25-026002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026002/ownership.xml","form_type":"4"}},{"id":1052718,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:55.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":34770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":34770,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":34770},"source":{"system":"sec-edgar","filing":"0001641172-25-026000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026000/ownership.xml","form_type":"4"}},{"id":1052717,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-08-29T20:30:55.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":26230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."}],"balance_after":60990,"source":{"system":"sec-edgar","filing":"0001641172-25-026000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026000/ownership.xml","form_type":"4"}},{"id":1052716,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:54.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":28576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":28576,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":28576},"source":{"system":"sec-edgar","filing":"0001641172-25-026005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026005/ownership.xml","form_type":"4"}},{"id":1052715,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:54.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":22283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":74994,"source":{"system":"sec-edgar","filing":"0001641172-25-026005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026005/ownership.xml","form_type":"4"}},{"id":1052714,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:52.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":134520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":134520,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":134520},"source":{"system":"sec-edgar","filing":"0001641172-25-026001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026001/ownership.xml","form_type":"4"}},{"id":1052713,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Common Stock","published_at":"2025-08-29T20:30:52.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":101480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 916 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":150036,"source":{"system":"sec-edgar","filing":"0001641172-25-026001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026001/ownership.xml","form_type":"4"}},{"id":1052707,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36756,"kind":"person","name":"Mirabelli Mary","position":1,"cik":"0001937525","reported_name":"Mirabelli Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:50.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":28576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":28576,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":28576},"source":{"system":"sec-edgar","filing":"0001641172-25-026004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026004/ownership.xml","form_type":"4"}},{"id":1052706,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36756,"kind":"person","name":"Mirabelli Mary","position":1,"cik":"0001937525","reported_name":"Mirabelli Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:50.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":22283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":73284,"source":{"system":"sec-edgar","filing":"0001641172-25-026004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026004/ownership.xml","form_type":"4"}},{"id":1052712,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:49.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":28576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":28576,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":28576},"source":{"system":"sec-edgar","filing":"0001641172-25-026006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026006/ownership.xml","form_type":"4"}},{"id":1052711,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":17074,"kind":"person","name":"Tyree James L","position":1,"cik":"0001324991","reported_name":"Tyree James L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T20:30:49.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":22283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":68074,"source":{"system":"sec-edgar","filing":"0001641172-25-026006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000164117225026006/ownership.xml","form_type":"4"}},{"id":1053014,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T20:30:47.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":142500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":142500,"derivative":{"exercise_price":3.64,"expiration_date":"2035-08-26","underlying":"Common stock","underlying_shares":142500},"source":{"system":"sec-edgar","filing":"0001641172-25-025999","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225025999/ownership.xml","form_type":"4"}},{"id":1053013,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-08-29T20:30:47.000Z","date":"2025-08-27","kind":"grant","planned":false,"acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter."}],"balance_after":159766,"source":{"system":"sec-edgar","filing":"0001641172-25-025999","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000164117225025999/ownership.xml","form_type":"4"}},{"id":1094629,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36758,"kind":"person","name":"Groen Eric","position":1,"cik":"0001918630","reported_name":"Groen Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:16:07.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on July 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":270000,"derivative":{"exercise_price":2.83,"expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001415889-25-019032","document":"form4-07022025_080748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925019032/form4-07022025_080748.xml","form_type":"4"}},{"id":1102533,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T20:10:04.000Z","date":"2025-06-06","kind":"gift","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":480501,"source":{"system":"sec-edgar","filing":"0001415889-25-018048","document":"form4-06242025_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925018048/form4-06242025_040601.xml","form_type":"4"}},{"id":1150641,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":79858,"kind":"person","name":"Ryder Sean","position":1,"cik":"0001937485","reported_name":"Ryder Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-05-13T21:05:41.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":4475,"price":2.92,"value":13067.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":47621,"source":{"system":"sec-edgar","filing":"0001415889-25-012809","document":"form4-05132025_050537.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925012809/form4-05132025_050537.xml","form_type":"4"}},{"id":1150640,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-13T21:05:39.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":10764,"price":2.92,"value":31430.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":191447,"source":{"system":"sec-edgar","filing":"0001415889-25-012808","document":"form4-05132025_050535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925012808/form4-05132025_050535.xml","form_type":"4"}},{"id":1150639,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Trial Operations"}}],"security":"Common Stock","published_at":"2025-05-13T21:05:37.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":5579,"price":2.92,"value":16290.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":47640,"source":{"system":"sec-edgar","filing":"0001415889-25-012807","document":"form4-05132025_050533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925012807/form4-05132025_050533.xml","form_type":"4"}},{"id":1151039,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2025-05-13T21:05:36.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":4737,"price":2.92,"value":13832.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":52266,"source":{"system":"sec-edgar","filing":"0001415889-25-012806","document":"form4-05132025_050531.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588925012806/form4-05132025_050531.xml","form_type":"4"}},{"id":1150638,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-05-13T21:05:32.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":1259,"price":2.92,"value":3676.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units."}],"balance_after":34760,"source":{"system":"sec-edgar","filing":"0001415889-25-012805","document":"form4-05132025_050529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925012805/form4-05132025_050529.xml","form_type":"4"}},{"id":1169596,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":41285,"kind":"person","name":"Smalling Ralph","position":1,"cik":"0001983288","reported_name":"Smalling Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Regulatory"}}],"security":"Common Stock","published_at":"2025-04-17T20:58:47.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":4172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025."}],"balance_after":36019,"source":{"system":"sec-edgar","filing":"0001415889-25-010881","document":"form4-04172025_080443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925010881/form4-04172025_080443.xml","form_type":"4"}},{"id":1169935,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1117,"kind":"person","name":"Cappello Joseph","position":1,"cik":"0001939198","reported_name":"Cappello Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Pharmaceutical Development"}}],"security":"Common Stock","published_at":"2025-04-17T20:57:32.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":13350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025."}],"balance_after":57003,"source":{"system":"sec-edgar","filing":"0001415889-25-010880","document":"form4-04172025_080429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1939198/000141588925010880/form4-04172025_080429.xml","form_type":"4"}},{"id":1169594,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1119,"kind":"person","name":"Yu Yong","position":1,"cik":"0001937482","reported_name":"Yu Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Trial Operations"}}],"security":"Common Stock","published_at":"2025-04-17T20:56:26.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":13350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025."}],"balance_after":53219,"source":{"system":"sec-edgar","filing":"0001415889-25-010879","document":"form4-04172025_080423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925010879/form4-04172025_080423.xml","form_type":"4"}},{"id":1169595,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":79858,"kind":"person","name":"Ryder Sean","position":1,"cik":"0001937485","reported_name":"Ryder Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2025-04-17T20:55:20.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":10708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025."}],"balance_after":52096,"source":{"system":"sec-edgar","filing":"0001415889-25-010878","document":"form4-04172025_080416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925010878/form4-04172025_080416.xml","form_type":"4"}},{"id":1169593,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":1118,"kind":"person","name":"Zindrick Thomas","position":1,"cik":"0001937573","reported_name":"Zindrick Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-17T20:54:13.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":30339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025."}],"balance_after":202211,"source":{"system":"sec-edgar","filing":"0001415889-25-010877","document":"form4-04172025_080409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588925010877/form4-04172025_080409.xml","form_type":"4"}},{"id":1287681,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36894,"kind":"person","name":"Pulisic Matthew","position":1,"cik":"0002054836","reported_name":"Pulisic Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-03T23:16:58.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest on January 30, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":275000,"derivative":{"exercise_price":3.95,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001415889-25-002798","document":"form4-02032025_110254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054836/000141588925002798/form4-02032025_110254.xml","form_type":"4"}},{"id":1319705,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36757,"kind":"person","name":"Thomas John","position":1,"cik":"0001939103","reported_name":"Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-12-31T18:20:10.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.96,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-030277","document":"form4a-12312024_011207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030277/form4a-12312024_011207.xml","form_type":"4/A","original_submission_date":"2024-08-05"}},{"id":1319704,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":36756,"kind":"person","name":"Mirabelli Mary","position":1,"cik":"0001937525","reported_name":"Mirabelli Mary","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-12-31T18:20:08.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.96,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-030276","document":"form4a-12312024_011205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030276/form4a-12312024_011205.xml","form_type":"4/A","original_submission_date":"2024-08-05"}},{"id":1319703,"issuer":{"id":1116,"kind":"organization","name":"GENELUX Corp","symbol":"GNLX"},"owners":[{"id":26570,"kind":"person","name":"Smither John W","position":1,"cik":"0001559583","reported_name":"Smither John W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option Right to Buy)","published_at":"2024-12-31T18:20:07.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":50469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50469,"derivative":{"exercise_price":1.96,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":50469},"source":{"system":"sec-edgar","filing":"0001415889-24-030275","document":"form4a-12312024_011203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231457/000141588924030275/form4a-12312024_011203.xml","form_type":"4/A","original_submission_date":"2024-08-05"}}],"next_cursor":"2024-12-31T18:20:07.000000Z,1319703"}